CoChat

DPP‐4 Inhibitor Linagliptin Attenuates A β‐induced Cytotoxicity through Activation of AMPK in Neuronal Cells

Open access
Kornelius, Edy, Lin, Chih‐Li, Chang, Hsiu‐Han, Li, Hsin‐Hua, Huang, Wen‐Nung, Yang, Yi‐Sun, Lu, Ying‐Li, Peng, Chiung‐Huei, Huang, Chien‐Ning · 2015 · CNS Neuroscience & Therapeutics
Cited by 123

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Summary: Aim: It is now clear that insulin signaling has important roles in regulation of neuronal functions in the brain. Dysregulation of brain insulin signaling has been linked to neurodegenerative disease, particularly Alzheimer's disease (AD). In this regard, there is evidence that improvement of neuronal insulin signaling has neuroprotective activity against amyloid β (A β)‐induced neurotoxicity for patients with AD. Linagliptin is an inhibitor of dipeptidylpeptidase‐4 (DPP‐4), which improves impaired insulin secretion and insulin downstream signaling in the in peripheral tissues. However, whether the protective effects of linagliptin involved in A β‐mediated neurotoxicity have not yet been investigated. Methods: In the present study, we evaluated the mechanisms by which linagliptin protects against A β‐induced impaired insulin signaling and cytotoxicity in cultured SK‐N‐MC human neuronal cells. Results: Our results showed that A β impairs insulin signaling and causes cell death. However, linagliptin significantly protected against A β‐induced cytotoxicity, and prevented the activation of glycogen synthase kinase 3 β (GSK 3 β) and tau hyperphosphorylation by restoring insulin downstream signaling. Furthermore, linagliptin alleviated A β‐induced mitochondrial dysfunction and intracellular ROS generation, which may be due to the activation of 5′ AMP‐activated protein kinase (AMPK)‐Sirt1 signaling. This upregulation of Sirt1 expression was also observed in diabetic patients with AD coadministration of linagliptin. Conclusions: Taken together, our findings suggest linagliptin can restore the impaired insulin signaling caused by A β in neuronal cells, suggesting DPP‐4 inhibitors may have therapeutic potential for reducing A β‐induced impairment of insulin signaling and neurotoxicity in AD pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cns.12404

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 123

Metadata

Authors
Kornelius, E., Lin, C., Chang, H., Li, H., Huang, W., Yang, Y., Lu, Y., Peng, C., & Huang, C.
Venue
CNS Neuroscience & Therapeutics
Publisher
Wiley
Published
2015-05-26
Volume
21
Issue
7
Pages
549-557
ISSN
  • 1755-5930 (ISSN-L)
  • 1755-5949
OpenAlex
W1549622883
Cited by
123
References
9
FWCI
6.67
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.